---
title: "Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut"
date: "2023-12-12T10:19:59.000Z"
publishedDate: "12 décembre 2023"
summary: "Pi-Cardia has appointed Gary Gratson to lead commercial operations for ShortCut, its dedicated leaflet modification device to enable transcatheter aortic valve implantation (TAVI) in patients at risk of coronary obstruction. The announcement comes after completion of enrolment in the ShortCut pivotal study in the USA and Europe in September 2023."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pi-cardia-appoints-gary-gratson-to-lead-commercialisation-of-shortcut/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-12-12-pi-cardia-appoints-gary-gratson-to-lead-commercialisation-of-shortcut"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/Gratson_Gary_02_cover-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pi-cardia-appoints-gary-gratson-to-lead-commercialisation-of-shortcut/"
---

![Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/Gratson_Gary_02_cover-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pi-cardia-appoints-gary-gratson-to-lead-commercialisation-of-shortcut/*

## L’essentiel

Pi-Cardia has appointed Gary Gratson to lead commercial operations for ShortCut, its dedicated leaflet modification device to enable transcatheter aortic valve implantation (TAVI) in patients at risk of coronary obstruction. The announcement comes after completion of enrolment in the ShortCut pivotal study in the USA and Europe in September 2023.

## Lien source

https://cardiovascularnews.com/pi-cardia-appoints-gary-gratson-to-lead-commercialisation-of-shortcut/
